Today: 30 April 2026
Amphenol stock price holds up near highs after India offer details; analysts lift targets into earnings
17 January 2026
2 mins read

Amphenol stock price holds up near highs after India offer details; analysts lift targets into earnings

New York, Jan 17, 2026, 16:58 EST — The market has closed.

  • Amphenol shares closed Friday at $154.39, edging up 0.1%, after fluctuating between $151.75 and $156.58.
  • The company announced a mandatory open offer for ADC India Communications after completing its CommScope CCS acquisition.
  • Goldman Sachs and BofA lifted their price targets as investors turn their attention to the earnings call set for Jan. 28.

Shares of Amphenol Corp ended Friday up 0.1% at $154.39, holding firm following a week packed with deal news and new price target upgrades from Wall Street ahead of the company’s upcoming earnings report.

U.S. markets are closed for the weekend and will remain shut Monday for Martin Luther King Jr. Day. Trading resumes Tuesday, when investors will focus on Amphenol’s earnings report due in late January.

This is significant since Amphenol’s shares often act as a stand-in for data-center expansions, where even slight shifts in demand outlook can trigger sharp valuation swings. The newest company update also marks another move toward integrating the CommScope connectivity assets it recently acquired.

On Jan. 15, Amphenol announced it will launch an open offer—a mandatory tender under Indian takeover laws—to buy up to 1.196 million shares of ADC India Communications. This represents 26% of the voting share capital held by public investors. The offer price stands at 1,233.59 rupees per share, which would total roughly $16.4 million in cash if fully subscribed. Notably, the offer isn’t subject to any minimum acceptance threshold, the company confirmed.

Goldman Sachs lifted its price target on Amphenol to $183 from $165, maintaining a Buy rating. The firm cited robust demand in data centers in its client note.

BofA raised its price target to $165 from $163 and kept its Buy rating intact. The firm’s preview note anticipates a quarterly beat paired with “conservative” guidance. It also boosted its FY26 revenue forecast to $31.2 billion, up from $30.0 billion, and lifted EPS estimates to $4.41 from $4.21. TipRanks

The open offer follows Amphenol’s completed acquisition of CommScope’s Connectivity and Cable Solutions business. Amphenol expects this to boost full-year 2026 sales by around $4.1 billion and add about $0.15 to diluted earnings per share, before acquisition-related costs. CEO R. Adam Norwitt highlighted that the deal “adds significant fiber optic interconnect capabilities” for IT datacom and communications networks markets. Amphenol Investors

The stock ended Friday with little movement as the broader market stayed subdued. The S&P 500 slipped 0.06%, while the Dow dropped 0.17%, per MarketWatch data.

Amphenol’s next share move likely depends less on the deal details and more on whether management can support those higher targets with solid guidance. Even a slight sign of weaker data-center orders, slower integration, or margin challenges could hit a stock already valued for steady growth.

Mark your calendar for Jan. 28, when Amphenol will host its fourth-quarter earnings call at 1:00 p.m. ET. Investors are eager to hear updates on how quickly the CCS integration is progressing, demand trends in communications networks and IT datacom, and whether any extra costs have emerged from bringing the new assets online.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
IonQ, Rigetti and QUBT move: what’s driving quantum computing stocks into next week
Previous Story

IonQ, Rigetti and QUBT move: what’s driving quantum computing stocks into next week

SMIC01 hits a record close in Thailand — what to watch next for the SMIC depositary receipt
Next Story

SMIC01 hits a record close in Thailand — what to watch next for the SMIC depositary receipt

Go toTop